563 Pharmacodynamics and pharmacokinetics of SO-C101 in cynomolgus monkeys by Ulrich Moebius, Radek Špíšek, David Béchard, Nada Podzimkova, Guy de Martynoff, Irena Adkins

484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors by Stephane Champiat, Aurélien Marabelle, Aung Naing, Filip Janku, Patricia LoRusso, David Béchard, Elena Garralda, Vladimir Galvao, Peter Grell, Richard Sachse, Joachim Kiemle-Kallee

713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients... by Ulrich Moebius, Radek Špíšek, David Béchard, Nada Podzimkova, Irena Adkins, Richard Sachse, Joachim Kiemle-Kallee, Ekaterina Simonova, Lenka Palova Jelinkova, Petr Danek, Martin Steegmaier

SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity by Zuzana Antosova, Nada Podzimkova, Nada Podzimkova, Jakub Tomala, Katerina Augustynkova, Katerina Sajnerova, Eva Nedvedova, Milada Sirova, Guy de Martynoff, David Bechard, Ulrich Moebius, Marek Kovar, Radek Spisek, Radek Spisek, Irena Adkins, Irena Adkins

Get full text

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy by Ulrich Moebius, Radek Špíšek, David Béchard, Zuzana Antosova, Nada Podzimkova, Irena Adkins, Klara Danova, Lenka Palova Jelinkova, Katerina Behalova, Petr Danek, Matej Fabisik, Kamila Hladikova, Nataliia Kalynovska, Lucie Kosinova, Pavel Marasek, Vladyslav Mazhara, Jan Praslicka, Katerina Sajnerova, Milada Sirova, Marek Kovar, Martin Steegmaier